All-trans retinoic acid in acute promyelocytic leukaemia

This publication has 47 references indexed in Scilit:

• Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial
  Leukemia, 2003
• Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol
  Leukemia, 2002
• Retinoic acid resistance in acute promyelocytic leukemia
  Leukemia, 2002
• All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
  Blood, 2002
• Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up
  Blood, 2002
• Frequent mutations in the ligand-binding domain of PML-RARα after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-transretinoic acid and histone deacetylase inhibitors in vitro and in vivo
  Blood, 2002
• Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
  Leukemia, 2000
• Early haemorrhagic morbidity and mortality during remission induction with or without all‐trans retinoic acid in acute promyelocytic leukaemia
  British Journal of Haematology, 2000
• Relapse in the External Auditory Canal of Acute Promyelocytic Leukemia after Treatment with All-Trans Retinoic Acid.
  Internal Medicine, 1997
• Tretinoin toxicity in children with acute promyelocytic leukaemia
  The Lancet, 1993